Correlation Between Spirent Communications and Mereo BioPharma

Can any of the company-specific risk be diversified away by investing in both Spirent Communications and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spirent Communications and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spirent Communications plc and Mereo BioPharma Group, you can compare the effects of market volatilities on Spirent Communications and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spirent Communications with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spirent Communications and Mereo BioPharma.

Diversification Opportunities for Spirent Communications and Mereo BioPharma

-0.43

Correlation Coefficient

Spirent Communications  Mereo BioPharma

Very good diversification

The 3 months correlation between Spirent and Mereo is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Spirent Communications plc and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Spirent Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spirent Communications plc are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Spirent Communications i.e., Spirent Communications and Mereo BioPharma go up and down completely randomly.

Pair Corralation between Spirent Communications and Mereo BioPharma

Assuming the 90 days trading horizon Spirent Communications plc is expected to generate 0.16 times more return on investment than Mereo BioPharma. However, Spirent Communications plc is 6.39 times less risky than Mereo BioPharma. It trades about 0.06 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.1 per unit of risk. If you would invest  17,670  in Spirent Communications plc on October 23, 2024 and sell it today you would earn a total of  160.00  from holding Spirent Communications plc or generate 0.91% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	94.74%
Values	Daily Returns

Spirent Communications plc  vs.  Mereo BioPharma Group

Spirent Communications

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Spirent Communications plc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, Spirent Communications is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Mereo BioPharma Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Spirent Communications and Mereo BioPharma

The main advantage of trading using opposite Spirent Communications and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spirent Communications position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.

The idea behind Spirent Communications plc and Mereo BioPharma Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.